MICHAEL O'BRIEN: Open Payments
NPI 1104887884 · HALFMOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 87 payments from 20 companies in 2025. Trend: 2023 $1,780 · 2024 $1,436 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $256 |
| PFIZER INC. | 17 | $248 |
| Novo Nordisk Inc | 5 | $123 |
| Amgen Inc. | 7 | $115 |
| Phathom Pharmaceuticals, Inc. | 7 | $93 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Abbott Laboratories | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Boston Scientific Corporation | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: NURTEC ODT, VRAYLAR, Wegovy, VOQUEZNA, UBRELVY, PREVNAR 20, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across NY — which companies pay providers there.
